Edaravone Injection, Solution
Product Images NDC 39822-4510

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Edaravone (NDC 39822-4510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 mg Carton (30 mg Carton Photo)

Edaravone Injection 30 mg/100 mL (0.3 mg/mL) single-dose vial carton by XGen Pharmaceuticals DJB, Inc. Label indicates it is for intravenous infusion, with two 100 mL single-dose vials per package. The label includes dosing instructions, storage conditions, and cautions related to use and handling.*

FDA Label Image

30 mg Vial (30 mg Vial Photo)

Edaravone Injection 30 mg/100 mL (0.3 mg/mL) single-dose vial label for intravenous infusion only. The label includes active ingredient edavarone 30 mg and inactive ingredients such as L-cysteine hydrochloride hydrate and sodium bisulfite. It details storage conditions, usage warnings, and manufacturer XGen Pharmaceuticals DJB, Inc., Big Flats, NY. The vial is 100 mL in volume and for single-dose use.*

FDA Label Image

60 mg Carton (60 mg Carton Photo)

Edaravone Injection 60 mg/100 mL (0.6 mg/mL) single-dose vial packaging label from XGen Pharmaceuticals DJB, Inc. The label includes directions for intravenous infusion over 60 minutes, lists active and inactive ingredients, storage instructions, and regulatory information including NDC 39822-4510-1. The design includes prominently displayed strength and usage details.*

FDA Label Image

60 mg Vial (60 mg Vial Photo)

Edaravone Injection 60 mg/100 mL (0.6 mg/mL) single-dose vial label by XGen Pharmaceuticals DJB, Inc. Contains active ingredient edaravone with specified inactive ingredients. Label indicates use for intravenous infusion only, dosing instructions, storage conditions, and caution statements about keeping out of reach of children and not swallowing.*

FDA Label Image

Edrv-structure (Edrv Structure)

Chemical structure of edaravone showing a bicyclic ring system with a ketone and methyl substituent.*

FDA Label Image

Figure-1 (Figure 1)

A bar chart comparing the percent of patients by change in ALSFRS-R score at week 24 between Edaravone Injection and placebo groups. The x-axis shows ranges of change in ALSFRS-R scores from worse to better, and the y-axis shows the percent of patients. Black bars represent Edaravone Injection, and white bars represent placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.